Presence of transthyretin amyloidosis cardiomyopathy influences the prognosis of patients with acute decompensated heart failure undergoing cardiac rehabilitation.
Yuta Nakaya, Masanori Akamatsu, Kaho Yakushiji
PMID 40895761WHAT IT FOUND
Patients with heart failure and transthyretin amyloidosis had similar physical function gains from rehab but much higher death and rehospitalization rates.
Good discharge scores did not predict their poor outcomes. Clinicians should not assume rehab success means a safe prognosis in this group.
Key findings
01Physical function improvements during cardiac rehab were similar in patients with and without transthyretin amyloidosis cardiomyopathy.
02After matching for other factors, patients with transthyretin amyloidosis cardiomyopathy had significantly higher rates of heart failure rehospitalization and death within one year.
03Early identification of transthyretin amyloidosis is essential because poor outcomes occur even when physical function appears preserved.
STILL TO COME
How it was doneWhat they foundWhat it means for PTsWhat it means for OTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study was conducted at a single center and was retrospective, which limits the generalizability of the findings. The number of patients with transthyretin amyloidosis was very small, especially after matching, which reduces statistical power. Patients taking tafamidis, a drug that may improve outcomes, were excluded, so the results do not reflect the full clinical population. Not all patients in the non-ATTR-CM group were tested for amyloidosis, so some patients with the condition may have been misclassified. Outpatient cardiac rehabilitation was not provided to all patients, which may have influenced the long-term outcomes.
Declared interests
The authors declared no conflicts of interest. The study received no external funding.
The easy way to misread this
Do not assume that a patient with transthyretin amyloidosis has a good prognosis simply because their physical function scores improved during cardiac rehabilitation. The study showed that despite similar gains in strength and walking speed, these patients had a much higher risk of death and rehospitalization compared to those without the condition.
Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →